🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Chuck Royce’s PTCT Holdings & Trades

First Buy
Q2 2014
Duration Held
8 Quarters
Largest Add
Q2 2025
+50,237 Shares
Current Position
92,828 Shares
$6.32 M Value

Chuck Royce's PTCT Position Overview

Chuck Royce (via Royce & Associates Lp) currently holds 92,828 shares of PTC Therapeutics, Inc. (PTCT) worth $6.32 M, representing 0.06% of the portfolio. First purchased in 2014-Q2, this short-term holding has been held for 8 quarters.

Based on 13F filings, Chuck Royce has maintained this position in PTCT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 50,237 shares. Largest reduction occurred in Q1 2015, reducing 50,000 shares.

Analysis based on 13F filings available since 2013 Q2

Chuck Royce's PTC Therapeutics (PTCT) Holding Value Over Time

Track share changes against reported price movement

Quarterly PTC Therapeutics (PTCT) Trades by Chuck Royce

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +12,034 Add 14.89% 92,828 $68.13
Q4 2025 +48,015 Add 146.48% 80,794 $75.96
Q3 2025 -17,458 Reduce 34.75% 32,779 $61.37
Q2 2025 +50,237 New Buy 50,237 $48.84
Q1 2015 -50,000 Sold Out 0 $0.00
Q2 2014 +50,000 New Buy 50,000 $26.14

Chuck Royce's PTC Therapeutics Investment FAQs

Chuck Royce first purchased PTC Therapeutics, Inc. (PTCT) in Q2 2014, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Chuck Royce has held PTC Therapeutics, Inc. (PTCT) for 8 quarters since Q2 2014.

Chuck Royce's largest addition to PTC Therapeutics, Inc. (PTCT) was in Q2 2025, adding 50,237 shares worth $2.45 M.

According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 92,828 shares of PTC Therapeutics, Inc. (PTCT), valued at approximately $6.32 M.

As of the Q1 2026 filing, PTC Therapeutics, Inc. (PTCT) represents approximately 0.06% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.

Chuck Royce's peak holding in PTC Therapeutics, Inc. (PTCT) was 92,828 shares, as reported at the end of Q1 2026.